Incannex Healthcare (IXHL) Income towards Parent Company (2022 - 2026)
Incannex Healthcare's (IXHL) quarterly Income towards Parent Company came in at -$3.9 million in Q1 2026, up 2.14% year-on-year from -$3.8 million in Q1 2025, and up 40.45% quarter-over-quarter from -$6.5 million in Q4 2025.
Incannex Healthcare (IXHL) Income towards Parent Company (2022 - 2026) Analysis & Trends
Incannex Healthcare has disclosed Income towards Parent Company across 5 years of filings, most recently posting -$3.9 million for Q1 2026.
- Income towards Parent Company for Q1 2026 came in at -$3.9 million, up 2.14% year-over-year; the trailing twelve-month figure through Mar 2026 was -$48.4 million (down 122.97% YoY), and the FY2025 annual result was -$46.9 million, down 154.0% from the prior year.
- Income towards Parent Company came in at -$3.9 million for Q1 2026 at Incannex Healthcare, up from -$6.5 million in the prior quarter.
- In the past five years, Income towards Parent Company ranged from a high of -$726000.0 in Q3 2023 to a low of -$31.6 million in Q2 2025.
- The 5-year median for Income towards Parent Company is -$5.3 million (2023), against an average of -$6.6 million.
- Across the five-year window, Income towards Parent Company slumped 646.56% in 2024 and surged 34.21% in 2025, its largest moves.
- Incannex Healthcare's Income towards Parent Company stood at -$2.9 million in 2022, then slumped by 79.61% to -$5.2 million in 2023, then fell by 12.46% to -$5.9 million in 2024, then decreased by 10.64% to -$6.5 million in 2025, then soared by 40.45% to -$3.9 million in 2026.
- The last three Income towards Parent Company figures came in at -$3.9 million (Q1 2026), -$6.5 million (Q4 2025), and -$6.4 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.77 Bn | 35.04 Bn | 1.97 Bn |
| 2 | Zoetis | 34.11 Bn | 32.16 Bn | 1.62 Bn |
| 3 | United Therapeutics | 23.68 Bn | 21.53 Bn | 648.10 Mn |
| 4 | Aurora Cannabis | 16.48 Bn | 16.40 Bn | 33.43 Mn |
| 5 | Neurocrine Biosciences | 16.19 Bn | 14.88 Bn | 800.70 Mn |
| 6 | Elanco Animal Health | 11.44 Bn | 11.01 Bn | 785.00 Mn |
| 7 | Alkermes | 7.28 Bn | 6.77 Bn | -116.06 Mn |
| 8 | Lantheus Holdings | 6.48 Bn | 5.98 Bn | 230.92 Mn |
| 9 | Hims & Hers Health | 6.35 Bn | 5.60 Bn | 396.79 Mn |
| 10 | Incannex Healthcare | 48.16 Mn | 48.16 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -3.88 Mn |
| Dec 31, 2025 | -6.52 Mn |
| Sep 30, 2025 | -6.41 Mn |
| Jun 30, 2025 | -31.60 Mn |
| Mar 31, 2025 | -3.97 Mn |
| Dec 31, 2024 | -5.89 Mn |
| Sep 30, 2024 | -5.42 Mn |
| Jun 30, 2024 | -6.43 Mn |
| Mar 31, 2024 | -6.03 Mn |
| Dec 31, 2023 | -5.24 Mn |
| Sep 30, 2023 | -726,000.00 |
| Jun 30, 2023 | -4.17 Mn |
| Mar 31, 2023 | -3.57 Mn |
| Dec 31, 2022 | -2.92 Mn |